These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 653211)
1. [Modifications of genetic markers during malignant blood disease]. Salmon C Rev Fr Transfus Immunohematol; 1978 Feb; 21(1):47-55. PubMed ID: 653211 [TBL] [Abstract][Full Text] [Related]
2. Blood groups changes in preleukemic states. Salmon C Nouv Rev Fr Hematol Blood Cells; 1976; 17(1-2):211-20. PubMed ID: 63942 [TBL] [Abstract][Full Text] [Related]
3. Multiple red cell antigen loss in acute granulocytic leukemia. Kolins J; Holland PV; McGinniss MH Cancer; 1978 Nov; 42(5):2248-53. PubMed ID: 281259 [TBL] [Abstract][Full Text] [Related]
4. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing. Pedersen-Bjergaard J; Philip P; Mortensen BT; Ersbøll J; Jensen G; Panduro J; Thomsen M Blood; 1981 Apr; 57(4):712-23. PubMed ID: 7470622 [No Abstract] [Full Text] [Related]
10. Profile of ABH & I antigens in leukaemia. Pourazar A; Joshi SR; Sathe MS; Advani SH; Bhatia HM Indian J Med Res; 1986 May; 83():505-8. PubMed ID: 3733206 [No Abstract] [Full Text] [Related]
11. Regulation of expression of carbohydrate blood group antigens. Watkins WM; Greenwell P; Yates AD; Johnson PH Biochimie; 1988 Nov; 70(11):1597-611. PubMed ID: 3149525 [TBL] [Abstract][Full Text] [Related]
12. Investigation of blood group antigens and carcinoembryonic antigen in urinary bladder carcinoma. Fujioka T; Ohhori T; Lovrekovich L; deKernion JB Urol Int; 1986; 41(6):397-402. PubMed ID: 3547992 [TBL] [Abstract][Full Text] [Related]
13. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients. Pedersen-Bjergaard J; Philip P; Pedersen NT; Hou-Jensen K; Svejgaard A; Jensen G; Nissen NI Cancer; 1984 Aug; 54(3):452-62. PubMed ID: 6733676 [TBL] [Abstract][Full Text] [Related]
14. Modifications of B, I, i, and Lewisb antigens in a patient with DiGuglielmo's erythroleukemia. Kolins J; Allgood JW; Burghardt DC; Klein HG; McGinniss MH Transfusion; 1980; 20(5):574-7. PubMed ID: 6932779 [TBL] [Abstract][Full Text] [Related]
15. [Development of antigens ABH and Ii in children between 0 to 16 years old]. Pawlak Z; Lopez M Rev Fr Transfus Immunohematol; 1979 Jun; 22(3):253-63. PubMed ID: 493796 [TBL] [Abstract][Full Text] [Related]
16. Hemoglobin abnormalities in neoplastic hematological disorders. Walker IR; Ali MA Can Med Assoc J; 1973 Apr; 108(7):843-7. PubMed ID: 4513360 [TBL] [Abstract][Full Text] [Related]
17. The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis. Greenberg P; Mara B; Bax I; Brossel R; Schrier S Am J Med; 1976 Dec; 61(6):878-91. PubMed ID: 1087534 [TBL] [Abstract][Full Text] [Related]
18. [Prolonged erythrocytic T activation, depression of blood group A and increase of fetal hemoglobin in a myelodysplastic syndrome evolving into erythroleukemia]. Gioseffi ON; Del Río F; Pardini P; Kitagawa M Sangre (Barc); 1991 Apr; 36(2):129-33. PubMed ID: 1714102 [TBL] [Abstract][Full Text] [Related]
19. Action of glycosyl transferases upon "Bombay" (Oh) erythrocytes. Conversion to cells showing blood-group H and A specificities. Schenkel-Brunner H; Prohaska R; Tuppy H Eur J Biochem; 1975 Aug; 56(2):591-4. PubMed ID: 1175638 [TBL] [Abstract][Full Text] [Related]
20. Activity of the human blood group ABO, Se, H, Le, and X gene-encoded glycosyltransferases in normal and malignant bladder urothelium. Orntoft TF; Wolf H; Watkins WM Cancer Res; 1988 Aug; 48(15):4427-33. PubMed ID: 3134126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]